HEMATOLOGICAL MALIGNANCIES

This study is testing two immunotherapy drugs, durvalumab and tremelimumab, in children and teens up to age 17 with advanced solid tumors or certain blood cancers that have not responded to standard treatments. The first part finds the safest dose, and the second part checks if t…

This early-stage study tests a new drug called talquetamab in people with multiple myeloma that has come back or stopped responding to other treatments. The drug is designed to help the immune system attack cancer cells. The main goals are to check safety and find the best dose f…

This study looks at whether weighted blankets can improve sleep in adults with blood cancers. Twenty participants will use the blankets, and researchers will monitor safety and any side effects. The goal is to see if this simple, drug-free approach can help patients rest better.

This study was designed to track how the immune system recovers after CAR-T cell therapy and to test a pneumococcal vaccine given six months later. It planned to enroll 50 adults with blood cancers or solid tumors. However, the study was withdrawn before any participants were enr…